MiR-630 suppresses breast cancer progression by targeting metadherin.

导出 OA

翻译打印收藏纠错

第一作者： Ci-Xiang,Zhou

第一单位： Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China.

作者： Ci-Xiang,Zhou ^[1] ; Chen-Long,Wang ^[1] ; An-Lu,Yu ^[1] ; Qiu-Yu,Wang ^[1] ; Meng-Na,Zhan ^[1] ; Jun,Tang ^[2] ; Xiu-Feng,Gong ^[1] ; Qian-Qian,Yin ^[1] ; Ming,He ^[1] ; Jian-Rong,He ^[3] ; Guo-Qiang,Chen ^[4] ; Qian,Zhao ^[1]

作者单位： Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China. ^[1] Institute of Health Sciences, SJTU-SM & Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai 200025, China. ^[2] Department of General Surgery, Rui-Jin Hospital, SJTU-SM, Shanghai 200025, China. ^[3] Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China.;Institute of Health Sciences, SJTU-SM & Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai 200025, China. ^[4]

关键词 MTDH breast cancer metastasis miR-630